©The Author(s) 2016.
World J Cardiol. Jan 26, 2016; 8(1): 41-56
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.41
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.41
Table 4 Adapted from the surgical treatment of atrial fibrillation guidelines by the European Association for Cardio-Thoracic Surgery Clinical Guidelines Committee guidelines
| Use of ablative modalities |
| Unipolar radiofrequency ablation |
| Concomitant unipolar RFA for AF treatment together with cardiac surgery is effective in restoration of sinus rhythm |
| Success rates vary between 54%-83% at medium term follow up (at least 12 mo) |
| Safe procedure - no additional risks |
| Success rates are higher with: paroxysmal or persistent AF, younger age, smaller LAD |
| Class IIa recommendation based on multiple small retrospective studies (Level C) |
| Bipolar radiofrequency ablation |
| Higher success rates in restoring sinus rhythm compared to no ablation in concomitant cardiac surgery |
| On average the cross clamp time is increased by 15 min |
| There is limited evidence to suggest superiority of bipolar over unipolar RFA |
| 1 prospective trial has provided evidence demonstrating superiority of bipolar RFA over microwave ablation |
| Class I recommendation based on 3 RCTs and multiple small prospective studies (Level A) |
| Cryoablation |
| Acceptable intervention for AF treatment during concomitant surgery with acceptable sinus rhythm conversion rates between 60%-82% at 12 mo |
| Cryoablation is most successful in patients suffering from paroxysmal as opposed to permanent AF (suggested by 6 out of 9 studies reviewed) |
| Class IIa recommendation based on 1 small RCT and multiple prospective and retrospective studies (Level B) |
| Microwave ablation |
| Less effective intervention for AF treatment based on the limited evidence |
| Success rates in the longer term are less clear - the only RCT to date has found outcomes inferior to RFA |
| Class III recommendation based on 1 small RCT and multiple small prospective and retrospective studies (Level B) |
| HIFU |
| Currently not recommended as an intervention for the treatment of AF during concomitant surgery outside clinical trials due to limited evidence |
| Success rates seem to be inferior to those of other devices |
| Significant concerns have been reported |
| Class III recommendation based on cohort studies (Level C) |
| Exclusion of laa and standing alone surgical ablation |
| Exclusion of LAA |
| No proven benefit of surgical LAA exclusion in terms of stroke reduction or mortality |
| Ineffective LAA occlusion and potentially increased stroke risk due to poor technique was seen in many studies |
| Devices designed for LAA exclusion should be preferentially used rather than a cut and sew or stapling technique, if LAA is to be performed |
| Class IIa recommendation based on multiple cohort studies and one pilot RCT (Level B) |
| Stand alone surgical ablation |
| Surgery can be considered for symptomatic patients who are refractory or intolerant to at least 1 anti-arrhythmic medication |
| Considered for patients with paroxysmal, long standing and persistent AF who prefer surgery to catheter ablation or have failed catheter ablation |
| Results of both catheter-based and surgery-based ablation should be discussed with the patient |
| Class IIa recommendations based on 1 RCT and multiple cohort studies (Level B) |
- Citation: Kyprianou K, Pericleous A, Stavrou A, Dimitrakaki IA, Challoumas D, Dimitrakakis G. Surgical perspectives in the management of atrial fibrillation. World J Cardiol 2016; 8(1): 41-56
- URL: https://www.wjgnet.com/1949-8462/full/v8/i1/41.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i1.41